Cooperating with Nan Cao, our lab published an article, which entitled “Co-effects of m6A and chromatin accessibility dynamics in the regulation of cardiomyocyte differentiation”, in Epigenetics & Chromatin on August 11th. Xue-Hong Liu is the co-first author. Ze-Hui Ren, Hong-Xuan Chen and Ying Zhang also made great contribution to this work. Congratulations to them!
N6-methyladenosine (m6A) is the most abundant and thoroughly studied RNA modification base in vertebrates. Currently, m6A detection is mainly based on second-generation sequencing methods, which have problems such as false positives, complex operations, and limited to site detection. Gradually, nanopore sequencing technology (Oxford Nanopore Technologies, ONT) has become an ideal alternative method. Although many highly complex and advanced computational tools have been developed to detect and quantify m6A via nanopore sequencing, there is still a lack of research to thoroughly evaluate and compare these tools.
On Jan. 14th, 2023, an annual meeting was held to review our work in the last year and to look forward to the future. This time, we were honored to invite Dr. Feng Guihai, Dr. Jia Xiaoyan, Dr. Xu Jin and Dr. Liu Li as guests to attend the meeting. Their insightful comments and generous advice eminently inspired all of us and were greatly appreciated!